Canadian Society of Transplantation Consensus Workshop on Cytomegalovirus Management in solid organ transplantation final report

被引:227
作者
Preiksaitis, JK [1 ]
Brennan, DC
Fishman, J
Allen, U
机构
[1] Univ Alberta, Prov Lab Publ Hlth Microbiol, Edmonton, AB, Canada
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] Massachusetts Gen Hosp, Div Infect Dis, Charlestown, MA USA
[4] Hosp Sick Children, Div Infect Dis, Toronto, ON M5G 1X8, Canada
关键词
cytomegalovirus; solid organ transplantation;
D O I
10.1111/j.1600-6143.2004.00692.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
The Canadian Society of Transplantation sponsored a Cytomegalovirus (CMV) Consensus Working Group that met on March 19, 2003. The objectives of this group were to determine the current burden of CMV-associated disease in the setting of solid organ transplantation in Canada, make recommendations regarding optimal strategies for the diagnosis, treatment and prevention of CMV infection and disease, highlight gaps in knowledge and outline priorities for research and other initiatives that might further reduce the burden of CMV-associated effects in this setting. This report summarizes the recommendations of the working group including ratings of the strength of evidence supporting the recommendations.
引用
收藏
页码:218 / 227
页数:10
相关论文
共 25 条
[1]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[2]   ANALYSIS OF TIME-DEPENDENT RISKS FOR INFECTION, REJECTION, AND DEATH AFTER PULMONARY TRANSPLANTATION [J].
BANDO, K ;
PARADIS, IL ;
KOMATSU, K ;
KONISHI, H ;
MATSUSHIMA, M ;
KEENAN, RJ ;
HARDESTY, RL ;
ARMITAGE, JM ;
GRIFFITH, BP .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (01) :49-59
[3]  
Bando K, 1995, J THORAC CARDIOVASC, P57
[4]  
Boeckh Michael, 2003, Herpes, V10, P12
[5]   Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation [J].
Emery, VC ;
Sabin, CA ;
Cope, AV ;
Gor, D ;
Hassan-Walker, AF ;
Griffiths, PD .
LANCET, 2000, 355 (9220) :2032-2036
[6]   Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation [J].
Emery, VC .
REVIEWS IN MEDICAL VIROLOGY, 2001, 11 (02) :83-86
[7]   Infection in organ-transplant recipients [J].
Fishman, JA ;
Rubin, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (24) :1741-1751
[8]   Preemptive therapy of cytomegalovirus disease in pediatric transplant recipients [J].
Green, M ;
Michaels, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (09) :875-877
[9]  
GRIFFITHS P, 2000, IHMF MAN STRAT WORKS
[10]   Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation [J].
Hart, GD ;
Paya, CV .
REVIEWS IN MEDICAL VIROLOGY, 2001, 11 (02) :73-81